A Covid-19 vaccine candidate on a shelf during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand. - AP
BANGKOK (Xinhua): Thailand's National Vaccine Institute on Monday (Nov 23) announced that two of seven Covid-19 vaccine candidates have been successfully tested on animals and are moving onto human trials.
The two candidates entering Phase 2 trials on humans are the mRNA vaccine being developed by Chula Vaccine Research Centre (Chula VRC) and the DNA vaccine developed by BioNet-Asia, said Dr. Nakorn Premsri, director of the institute.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
